Stanford University
Showing 1,641-1,660 of 37,045 Results
-
Muriel Babey
Assistant Professor of Medicine (Endocrinology)
BioMuriel Babey, M.D. is an Assistant Professor of Medicine in the Division of Endocrinology, Gerontology & Metabolism at Stanford University. She is a physician–scientist who specializes in metabolic bone disease and osteoporosis, with a focus on skeletal health during reproductive transitions and aging, as well as disorders of calcium and parathyroid metabolism.
Originally from Switzerland, Dr. Babey earned her medical degree in Switzerland and completed fellowship training in Endocrinology at the University of California, San Francisco. During her postdoctoral training in the laboratory of Holly Ingraham at UCSF, her work focused on identifying CCN3 as a maternal brain–derived osteoanabolic hormone critical for lactation, uncovering a previously unrecognized neuroendocrine axis regulating bone formation and marrow adiposity.
Dr. Babey directs a research program that integrates human cohort studies with mechanistic models to define endocrine pathways coordinating skeletal and metabolic resilience across reproductive transitions and aging. Her work centers on identifying secreted factors and interorgan communication networks that regulate bone health, with the goal of advancing translational strategies for osteoporosis and related metabolic diseases. Her research is supported by an NIH K08 award, and she is a recipient of the Endocrine Society Early Investigator Award and the ASBMR John Haddad Early Investigator Award. -
Mohan Babu Budikote Venkatappa
Basic Life Research Scientist, Genetics
Current Research and Scholarly InterestsLongitudinal deep omics profiling to understand health and disease trajectories
-
Rosa Bacchetta
Professor (Research) of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsIn the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.
Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.
For further information please visit the Bacchetta Lab website:
http://med.stanford.edu/bacchettalab.html -
Stephen A. Baccus
Professor of Neurobiology
Current Research and Scholarly InterestsWe study how the neural circuitry of the vertebrate retina encodes visual information and performs computations. To control and measure the retinal circuit, we present visual images while performing simultaneous two-photon imaging and multielectrode recording. We perturb the circuit as it operates using simultaneous intracellular current injection and multielectrode recording, and use the resulting large data sets to construct models of retinal computation.
-
Florian Bach
Postdoctoral Scholar, Infectious Diseases
BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda. I am a Global Health Postdoctoral Affiliate with the Stanford Center for Innovation in Global Health.
